GM
George J Morrow (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $2.2M of NBIX (13,900 sh across 8 lots, as filed), executed Nov 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Nov 3
Filed Nov 3
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NBIXRecent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$2.2M13,900 sh across 8 lots
Exec Nov 2
Filed Nov 3 · 6:52 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $2.2M
15,000 sh × $143.37
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET